[1]
Singh, R.S., Ingle, S.S. and Dehankar, M.R. 2026. Comparative glycemic efficacy and safety of sitagliptin versus gliclazide in uncomplicated type 2 diabetes mellitus: a 6-month prospective study . International Journal of Basic & Clinical Pharmacology. 15, 4 (Jun. 2026), 718–722. DOI:https://doi.org/10.18203/2319-2003.ijbcp20261960.